|
Volumn , Issue 118, 2005, Pages 20-25
|
Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins.
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ANTIOXIDANT;
DRUG DERIVATIVE;
LIPID;
NITRIC OXIDE;
SIMVASTATIN;
TRIACYLGLYCEROL;
UBIDECARENONE;
UBIQUINONE;
ARTICLE;
BLOOD;
COMPARATIVE STUDY;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
DRUG COMBINATION;
EVALUATION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
OXIDATIVE STRESS;
STATISTICAL ANALYSIS;
THROMBOCYTE AGGREGATION;
TIME;
TREATMENT OUTCOME;
ANTILIPEMIC AGENTS;
ANTIOXIDANTS;
CORONARY ARTERIOSCLEROSIS;
CORONARY ARTERY BYPASS;
CORONARY DISEASE;
DATA INTERPRETATION, STATISTICAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
LIPIDS;
MALE;
MIDDLE AGED;
NITRIC OXIDE;
OXIDATIVE STRESS;
PLATELET AGGREGATION;
SIMVASTATIN;
TIME FACTORS;
TREATMENT OUTCOME;
TRIGLYCERIDES;
UBIQUINONE;
|
EID: 17544383975
PISSN: 15120112
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (18)
|
References (0)
|